Organon & Co | OGN - Marktkapitalisierung

Aktienkurs
6.08
Täglich Wechseln
0.03 0.50%
Monatlich
-6.89%
Jährlich
-47.47%
Q2 Prognose
6.17




Marktkapitalisierung Veränderung Datum
Bristol-Myers Squibb USD 109.81B 18.01B 2025-12
Cspc Pharmaceutical CNY 87.29B 19.74B 2025-12
Deva Holding AS TRY 17.54B 7.76B 2023-09
Dianthus Therapeutics USD 1.78B 215M 2025-12
Divis Laboratories Ltd INR 1.7T 186.62B 2025-12
Gilead Sciences USD 152.28B 14.55B 2025-12
Glaxosmithkline GBP 99.93B 13.05B 2025-12
Kangmei Pharma CNY 27.93B 1.73B 2025-09
Knight Therapeutics CAD 600.53M 14.56M 2025-12
Laboratorios Farma EUR 4.17B 917.16M 2026-03
Malin Corporation EUR 142.92M 19.65M 2026-02
Medical Developments International AUD 62.53M 563.29K 2025-12
Merck USD 261.26B 51.62B 2025-12
Neuren Pharmaceuticals AUD 2.36B 606.56M 2025-12
Novartis USD 263.08B 17.01B 2025-12
Organigram Holdings CAD 312.16M 66.64M 2025-12
Organon & Co USD 1.86B 916.43M 2025-12
Ovoca Bio EUR 6.12M 4.93M 2026-04
Pharma Mar EUR 1.35B 283.5M 2025-12
Qiagen NV USD 9.9B 207.4M 2025-12
Sartorius EUR 16.41B 2.95B 2025-12
Zealand Pharma A/S 33.35B 0 2026-04